MINISTER OF STATE IN THE MINISTRY OF CHEMICALS AND FERTILIZERS AND MINISTER OF STATE
IN THE MINISTRY OF PARLIAMENTARY AFFAIRS (SHRI B.K. HANDIQUE)
(a) to (e) : The 74 bulk drugs specified in the First Schedule of the Drugs (Prices Control)
Order, 1995 (DPCO, 95) and the formulations based thereon are under price control and their
prices are fixed / revised by the National Pharmaceutical Pricing Authority (NPPA) in
accordance with the provisions of the DPCO, 95.
Prices of non-Scheduled formulations are fixed by the manufacturers themselves keeping
in view the various factors like cost of production, marketing/selling expenses, R&D expenses,
trade commission, market competition, product innovation, product quality etc. The Government
takes corrective measures where the public interest is found to be adversely affected.
As per Para 13 of DPCO,95, notwithstanding anything contained in the order, the Government
shall by notice, require the manufacturers, importers, as the case may be, to deposit the
amount accrued due to charging of prices higher than those fixed or notified by the Government.
In case of non-Scheduled formulations NPPA only monitors the price movement and if
there is any price increase by more than 10% in one year and the annual turnover of the
formulation pack exceeds Rs.1 crore, further, the share of the formulator in the segment of
the formulation is required to be at least 20% of the market or the medicine is first 3 top
medicines of that group. The case is take up for further examination and if required prices
are fixed in public interest under Para 10(b) of DPCO,95,. So far 30 companies have reduced
the price of 51 packs as a result of the intervention of NPPA/Government. NPPA have fixed the
price of 20 packs under Para 10(b) of DPCO,95.